mortality/aging
|
• mice die within the first 3 to 4 weeks due to multiorgan failure
• however, mice treated with sodium nitrite, arginine, arginine and sodium benzoate, or all three therapies exhibit improved survival
|
immune system
|
• thin
|
|
• in the spleen and thymus
|
|
• in the thymus cortex
|
homeostasis/metabolism
|
• mice exhibit decreased plasma arginine levels compared with wild-type mice
|
|
• mice exhibit increased plasma citrulline levels compared with wild-type mice
|
|
• decreased nitrosylation in the liver and heart
|
cardiovascular system
|
• atrophic in the myocardium
|
|
• however, mice treated with sodium nitrite, arginine and sodium benzoate exhibit normalizes blood pressure
|
|
• however, mice treated with sodium nitrite, arginine and sodium benzoate exhibit normalizes blood pressure
|
|
• impaired in response to acetylcholine treatment
• however, relaxation in response to sodium nitroprusside is normal
|
integument
|
• abnormal hair patterning by 2 weeks of age
|
|
• small and disorganized
|
|
• atrophic
|
growth/size/body
|
• at 3 and 4 weeks of age
• however, mice treated with sodium nitrite or sodium nitrite, arginine and sodium benzoate exhibit increased weight
|
|
• by 2 weeks of age
|
renal/urinary system
|
• smaller than in wild-type mice
|
muscle
|
• atrophic in the myocardium
|
|
• impaired in response to acetylcholine treatment
• however, relaxation in response to sodium nitroprusside is normal
|
hematopoietic system
|
• thin
|
|
• mice exhibit more numerous acanthocytes and fewer spherocytes than in wild-type mice
|
|
• more numerous acanthocytes than in wild-type mice
|
|
• in the spleen and thymus
|
|
• in the thymus cortex
|
endocrine/exocrine glands
|
• thin
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| argininosuccinic aciduria | DOID:14755 |
OMIM:207900 |
J:196817 | |


Analysis Tools